Verrica Pharmaceuticals
VRCA
VRCA
63 hedge funds and large institutions have $84.2M invested in Verrica Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.39% more ownership
Funds ownership: 3.09% → 3.48% (+0.39%)
0% more capital invested
Capital invested by funds: $84.2M → $84.2M (+$83.2K)
Holders
63
Holding in Top 10
–
Calls
$446K
Puts
$193K
Top Buyers
| 1 | +$5.17M | |
| 2 | +$1.78M | |
| 3 | +$1.75M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$795K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$1.14M | |
| 3 | -$867K | |
| 4 |
Morgan Stanley
New York
|
-$673K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$490K |